CSF Shunt Market: By Type (Fixed CSF Shunts and Adjustable CSF Shunts), By Application (Hospitals and Neurological Centres, Clinics and Ambulatory Surgical Centres) and Geography

CSF Shunt Market size was valued at USD 1,783.2 million in 2023 and is poised to grow at 4.9% CAGR during the forecast years (2024-2030). A shunt is a thin, flexible tube inserted into the ventricles of the brain, the region where CSF is forming. The shunt's function is to drain the extra fluid that is pushing up against the brain's internal pressure. The rising incidence of conditions requiring CSF shunts, such as hydrocephalus, is driving demand for these medical devices. For instance, in 2019, neurological disorders were responsible for about 9.7 million deaths globally, and this number has been increasing. Also, the growing elderly population, which is more susceptible to conditions like normal pressure hydrocephalus, increases the demand for CSF shunt systems. Whereas, high cost and potential complications such as infection, shunt malfunction, and the need for surgical revisions can be a restraining factor for the CSF shunt market. However, developing new, more effective, and patient-friendly shunt technologies can capture market share and meet evolving medical needs. Additionally, collaborations between medical device companies and healthcare institutions can foster innovation and expand market reach.

CSF Shunt Market Key Developments:

• In 2023: Medtronic launched a new programmable shunt system that allows for more precise control and adjustment of cerebrospinal fluid flow. This system improves patient outcomes and reduces the need for surgical revisions.
• In 2022: B. Braun introduced a new, enhanced version of their Strata NSC Valve, designed to reduce the incidence of shunt malfunction and improve patient comfort.